|
|
|
42
|
39216
|
PLAVIX 75MG TAB (SFA) CLOPIDOGREL
|
CLOPIDOGREL
|
PLAVIX
|
28'S
|
C
|
81.55
|
2.91
|
TAB
|
30
|
BLIS
|
SFA
|
SANOFI
|
COL
|
AVENTA BARBADOS
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
40
|
3921BS
|
CLOPIDOGREL 75MG TAB (KWA/ATB)
|
CLOPIDOGREL
|
CLOPIDOGREL
|
100'S
|
A
|
8.07
|
0.08
|
TABLET
|
30
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-06-02
|
|
|
|
40
|
3921CH
|
BRILINTA 90MG TAB (AZN/COL) TICAGRELOR
|
TICAGRELOR
|
BRILINTA
|
60'S
|
C
|
122.32
|
2.04
|
TABLET
|
0
|
TAB
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
3921CH
|
BRILINTA 90MG TAB (AZN) TICAGRELOR (C)
|
TICAGRELOR
|
BRILINTA
|
60'S
|
C
|
122.32
|
2.0387
|
TAB
|
60
|
BOX
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
42
|
3921CH
|
BRILINTA 90MG TAB (AZN) TICAGRELOR
|
TICAGRELOR
|
BRILINTA
|
60'S
|
C
|
121.54
|
2.03
|
TAB
|
60
|
BLIS
|
AZN
|
ASTRAZENECA AB
|
COL
|
AVENTA BARBADOS
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
40
|
3921CK
|
PLASEP 75MG TAB (MSN/ATB) CLOPIDOGREL
|
CLOPIDOGREL
|
PLASEP
|
3X10
|
A
|
1.77
|
0.06
|
TABLET
|
30
|
TAB
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-04-01
|
2022-07-26
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
40
|
3921CK
|
PLASEP 75MG TAB (MSN/ATB) CLOPIDOGREL
|
CLOPIDOGREL
|
PLASEP
|
3X10
|
A
|
2.16
|
0.07
|
TABLET
|
30
|
TAB
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-09-06
|
2024-03-31
|
Price Change
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-07-26
|
|
|
|
41
|
3921CK
|
PLASEP 75MG TAB (MSN) CLOPIDOGREL
|
CLOPIDOGREL
|
PLASEP
|
3X10
|
A
|
2.64
|
0.0879
|
TAB
|
30
|
BOX
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
40
|
3921CM
|
DIPYRIDAMOLE 50MG TAB (LDP/AHI)
|
DIPYRIDAMOLE
|
DIPYRIDAMOLE
|
100'S
|
BQ
|
49.72
|
0.50
|
TABLET
|
120
|
TAB
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat B
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-03-10
|
|
|
|
40
|
3921CQ
|
DIPYRIDAMOLE 25MG TAB (LDP/AHI)
|
DIPYRIDAMOLE
|
DIPYRIDAMOLE
|
100'S
|
BQ
|
49.72
|
0.50
|
TABLET
|
120
|
TAB
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat B
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-03-10
|
|
|
|
40
|
3921CS
|
DIPYRIDAMOLE 75MG TAB (LDP/AHI)
|
DIPYRIDAMOLE
|
DIPYRIDAMOLE
|
100'S
|
BQ
|
49.72
|
0.50
|
TABLET
|
120
|
TAB
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat B
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-03-10
|
|
|
|
41
|
3921DM
|
CLOPIDOGREL 75MG TAB (MCP)
|
CLOPIDOGREL
|
CLOPIDOGREL
|
10X10
|
A
|
6.93
|
0.0693
|
TAB
|
30
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
42
|
3921EA
|
BRIREM 90MG TAB (REM) TICAGRELOR
|
TICAGRELOR
|
BRIREM
|
14X4
|
B
|
27.46
|
0.49
|
TAB
|
60
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
42
|
3921ER
|
PLASEP 75MG TAB (MSN) CLOPIDOGREL
|
CLOPIDOGREL
|
PLASEP
|
3X10
|
A
|
2.47
|
0.08
|
TAB
|
30
|
|
MSN
|
MSN LABS
|
STO
|
BRYDEN STOKES LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
PLATELET AGGREGATION INHIBITORS
|
2026-03-23
|
|
|
|
40
|
3921K
|
ANTIPLAR 75MG TAB (EMC/COL) CLOPIDOGREL
|
CLOPIDOGREL
|
ANTIPLAR
|
100'S
|
A
|
9.51
|
0.10
|
TABLET
|
30
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-05-31
|
2022-12-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-05-31
|
|
|
|
41
|
3921K
|
ANTIPLAR 75MG TAB (EMC) CLOPIDOGREL
|
CLOPIDOGREL
|
ANTIPLAR
|
100'S
|
A
|
8.7
|
0.087
|
TAB
|
30
|
BOX
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
42
|
3921K
|
ANTIPLAR 75MG TAB (EMC) CLOPIDOGREL
|
CLOPIDOGREL
|
ANTIPLAR
|
100'S
|
A
|
8.70
|
0.09
|
TAB
|
30
|
BLIS
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
42
|
39612
|
APO-VALPROIC 250MG CAP (APO)
|
VALPROIC ACID
|
APO-VALPROIC
|
100'S
|
A
|
38.06
|
0.38
|
CAP
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
3961AD
|
DEPAKOTE ER 250MG TAB (ABB/PHA) VALPROIC ACID
|
VALPROIC ACID
|
DEPAKOTE ER
|
100'S
|
A
|
71.36
|
0.71
|
TABLET
|
90
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
3961AD
|
DEPAKOTE ER 250MG TAB (ABB/PHA) VALPROIC ACID
|
VALPROIC ACID
|
DEPAKOTE ER
|
100'S
|
A
|
71.36
|
0.7136
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
2023-03-02
|